{"id":"https://openalex.org/W1995812017","doi":"https://doi.org/10.1111/j.1600-0404.1993.tb04254.x","title":"Cholinergic therapy in dementia","display_name":"Cholinergic therapy in dementia","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-29","ids":{"openalex":"https://openalex.org/W1995812017","doi":"https://doi.org/10.1111/j.1600-0404.1993.tb04254.x","mag":"1995812017","pmid":"https://pubmed.ncbi.nlm.nih.gov/8128838"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0404.1993.tb04254.x","doi":"https://doi.org/10.1111/j.1600-0404.1993.tb04254.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1993.tb04254.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995812017"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017640771","display_name":"Peter John Whitehouse","orcid":"https://orcid.org/0000-0001-9581-969X","observed_orcids":["https://orcid.org/0000-0001-9581-969X"]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"P. J. Whitehouse","raw_affiliation_strings":["Alzheimer Center, University Hospitals of Cleveland, Case Western Reserve University, Ohio 44106"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer Center, University Hospitals of Cleveland, Case Western Reserve University, Ohio 44106","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017640771"],"corresponding_institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I58956616"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":null,"fwci":0.3435,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.25272331,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"88","issue":"S149","first_page":"42","last_page":"45"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.06870000064373016,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.04670000076293945,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholinergic-therapy","display_name":"cholinergic therapy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/dementia","display_name":"dementia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cholinomimetic-drugs","display_name":"cholinomimetic drugs","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tacrine","display_name":"tacrine","score":1.0},{"id":"https://openalex.org/keywords/muscarinic-receptor-agonists","display_name":"muscarinic agonists","score":0.9399999976158142},{"id":"https://openalex.org/keywords/nicotinic-agonists","display_name":"nicotinic agonists","score":0.9700000286102295}],"concepts":[{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.9595533609390259},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.7361757755279541},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.7206653356552124},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5937454700469971},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.5879276394844055},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.533200204372406},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.524016261100769},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.47717538475990295},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.47365888953208923},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.42971283197402954},{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.41069212555885315},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3685634732246399},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.31655430793762207},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3050336241722107},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.26938414573669434},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20811623334884644},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1511366367340088},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09151804447174072},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011976","descriptor_name":"Receptors, Muscarinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0404.1993.tb04254.x","doi":"https://doi.org/10.1111/j.1600-0404.1993.tb04254.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1993.tb04254.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmid:8128838","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8128838","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica. Supplementum","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1972300483","https://openalex.org/W1980466462","https://openalex.org/W1982064952","https://openalex.org/W1983320084","https://openalex.org/W1988485844","https://openalex.org/W1994067502","https://openalex.org/W1998922851","https://openalex.org/W2004529130","https://openalex.org/W2057825189","https://openalex.org/W2068987805","https://openalex.org/W2077525784","https://openalex.org/W2077706021","https://openalex.org/W2088686092","https://openalex.org/W2093374391","https://openalex.org/W2095477109","https://openalex.org/W2097326214","https://openalex.org/W2133948124","https://openalex.org/W2135134101","https://openalex.org/W2146073951","https://openalex.org/W2166983264","https://openalex.org/W2253547254","https://openalex.org/W2272461430","https://openalex.org/W2314133009","https://openalex.org/W2315512533","https://openalex.org/W2341364136","https://openalex.org/W4232629811","https://openalex.org/W4299669364","https://openalex.org/W4388311259","https://openalex.org/W4388311307","https://openalex.org/W7221026529"],"related_works":["https://openalex.org/W581972262","https://openalex.org/W2065756284","https://openalex.org/W4241642978","https://openalex.org/W2053306852","https://openalex.org/W7095309486","https://openalex.org/W2413292111","https://openalex.org/W1988838126","https://openalex.org/W2056489579","https://openalex.org/W1480859043","https://openalex.org/W2066323408"],"abstract_inverted_index":{"After":[0],"reviewing":[1],"the":[2,32,37,66],"evidence":[3],"for":[4,17],"cholinergic":[5,46],"pathology":[6],"in":[7],"Alzheimer's":[8,69],"disease":[9],"and":[10,44],"related":[11],"disorders,":[12],"this":[13],"paper":[14],"reviews":[15],"strategies":[16,63],"treating":[18],"dementia":[19],"using":[20],"cholinomimetic":[21],"drugs.":[22],"Special":[23],"attention":[24],"is":[25],"paid":[26],"to":[27,64],"cholinesterase":[28],"inhibitors,":[29],"particularly":[30],"tacrine,":[31],"drug":[33],"recently":[34],"approved":[35],"by":[36],"FDA.":[38],"New":[39],"studies":[40],"suggesting":[41],"that":[42],"muscarinic":[43],"nicotinic":[45],"receptor":[47],"active":[48],"drugs":[49],"may":[50],"be":[51,55,60],"more":[52],"effective":[53],"will":[54,59],"reviewed.":[56],"Brief":[57],"mention":[58],"made":[61],"of":[62,68],"slow":[65],"progression":[67],"disease.":[70]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995812017","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
